Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting

BACKGROUND: Limited adjuvant treatment options exist for patients with high-risk surgically resected melanoma. This first-in-human study investigated the safety, tolerability and immunologic correlates of Melanoma GVAX, a lethally irradiated granulocyte–macrophage colony stimulating factor (GM-CSF)-...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Transl Med
Hoofdauteurs: Lipson, Evan J, Sharfman, William H, Chen, Shuming, McMiller, Tracee L, Pritchard, Theresa S, Salas, January T, Sartorius-Mergenthaler, Susan, Freed, Irwin, Ravi, Sowmya, Wang, Hao, Luber, Brandon, Sproul, Janice Davis, Taube, Janis M, Pardoll, Drew M, Topalian, Suzanne L
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2015
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4491237/
https://ncbi.nlm.nih.gov/pubmed/26143264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-015-0572-3
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items